title: Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients.
authors.forename: V
authors.initials: V
authors.lastname: Pitini
authors.forename: C
authors.initials: C
authors.lastname: Arrigo
authors.forename: G
authors.initials: G
authors.lastname: Aloi
authors.forename: M
authors.initials: M
authors.lastname: Righi
authors.forename: M
authors.initials: M
authors.lastname: Falduto
authors.forename: D
authors.initials: D
authors.lastname: Teti
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000601:surgery; D005472:Fluorouracil / Q000633:toxicity*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil